Immunoprecise Antibodies Ltd (NASDAQ:IPA) Secures 2nd VLAIO Research Grant

May 11, 2022

The medical sector has almost always been on the radars of investors and there are many companies to look into if one wishes to discover stocks. At this point in time, one of the companies that investors could consider looking into is Immunoprecise Antibodies Ltd  (NASDAQ:IPA). On Monday, the company was in considerable focus after it made an announcement with regards to one of its subsidiary units on Monday. The…

Read More >>

ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) (IPA.V) Stock Outperforms Broader Market

April 18, 2022

It is often noticed that investors are increasingly prone to look into those stocks which may have clocked considerable gains over a reasonable period of time and hence, it may be a good time to look into the ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) (IPA.V) stock. The stock has been in the middle of a major rally in recent weeks and over the course of the past month, it has managed to…

Read More >>

Immunoprecise Antibodies Ltd (NASDAQ:IPA) To Acquire BioStrand BV – Revolutionizing Biotherapeutics

March 30, 2022

At this point in time, there could be a fair degree of focus on the Immunoprecise Antibodies Ltd (NASDAQ:IPA) (TSX.V:IPA) stock, which came into the news cycle earlier on in the week on Tuesday. At the time the company made a key announcement and it may be a good idea for investors to consider taking a look at it a bit more closely. The company announced that it had signed…

Read More >>

ImmunoPrecise Antibodies Ltd (NASDAQ:IPA): Marshall Wace LLP Raises Stock Position

March 7, 2022

NASDAQ listed innovative biotherapeutic company ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) could be the stock to watch today and especially after a major development that took place towards the end of February. Back on February 27, 2022, it emerged that existing institutional investors in the company Marshall Wace LLP had decided to grow their stake in ImmunoPrecise. Key Details When an existing investor raises his stake considerably then it is an indication…

Read More >>